Skip to Content


Barbara W. Bodem


Barbara W. Bodem joined Option Care Health's board of directors in January 2024.  She is an independent director and member of the Audit Committee and the Nominating & Corporate Governance Committee of the Board.

Ms. Bodem recently served as interim Chief Financial Officer for Dentsply Sirona Inc., the world's largest manufacturer of professional dental products and technologies. This follows her time as Senior Vice President and Chief Financial Officer for Hill-Rom (2018-2021), a medical technology provider that was acquired by Baxter International, Inc., and as Senior Vice President of finance for Mallinckrodt Pharmaceuticals (2015-2018).  She also held various leadership roles at Hospira (2013-2015), Eli Lilly and Company (1997-2013), and Irwin Management Company (1989-1997).

Ms. Bodem is an accomplished business leader and experienced board director with expertise in healthcare.  She currently serves on two other public company boards: Enovis Corporation (NYSE: ENOV) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN).